Myriad Genetics (MYGN) Earnings Date, Estimates & Call Transcripts $4.25 +0.36 (+9.25%) Closing price 04:00 PM EasternExtended Trading$4.13 -0.12 (-2.92%) As of 04:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Myriad Genetics Earnings Summary Myriad Genetics issued Q1 2025 earnings on May 6, 2025, reporting an EPS of -$0.03, which topped analysts' consensus estimates of -$0.05 by $0.02. Quarterly revenue fell 33.6% year-over-year to $195.90 million, below the consensus estimate of $200.37 million. With a trailing EPS of -$1.12, Myriad Genetics' earnings are expected to remain at ($0.30) per share in the coming year. Latest Q1 Earnings DateMay. 6EstimatedConsensus EPS (May. 6) -$0.05 Actual EPS (May. 6) -$0.03 Beat By $0.02 Actual Revenue (May. 6) $195.90MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Slide Deck Quarterly Report (10-Q)SEC FilingSlide DeckFull Screen Slide DeckPowered by Get Myriad Genetics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Myriad Genetics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataMYGN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MYGN Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Myriad Genetics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue GuidanceQ1 20251-$0.18-$0.18-$0.18Q2 20251-$0.06-$0.06-$0.06Q3 20251-$0.05-$0.05-$0.05Q4 20251-$0.03-$0.03-$0.03 FY 2025 4 -$0.32 -$0.32 -$0.32 Q1 20261-$0.14-$0.14-$0.14Q2 20261-$0.01-$0.01-$0.01Q3 20261-$0.01-$0.01-$0.01Q4 20261$0.02$0.02$0.02 Myriad Genetics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails5/6/2025Q1 2025-$0.05-$0.03+$0.02-$200.37M$195.90M2/25/2025Q4 2024$0.03-$0.09 -$0.12-$0.47$210.35M$210.60M11/7/2024Q3 2024$0.0180-$0.06 -$0.0780$0.12$209.82M$213.30M8/6/2024Q2 2024-$0.01$0.05+$0.06$0.21$206.44M$211.50M5/7/2024Q1 2024-$0.10-$0.01+$0.09$0.01$193.51M$202.20M2/27/2024Q4 2023$0.01$0.04+$0.03$0.22$194.80M$196.60M11/6/2023Q3 2023-$0.08-$0.03+$0.05$0.41$179.23M$191.90M8/3/2023Q2 2023-$0.08-$0.08-$1.00$187.16M$183.50M Myriad Genetics Earnings - Frequently Asked Questions When did Myriad Genetics announce their last quarterly earnings? Myriad Genetics (NASDAQ:MYGN) last announced its quarterly earning data on Tuesday, May 6, 2025. Learn more on MYGN's earnings history. What guidance has Myriad Genetics issued on next quarter's earnings? Myriad Genetics updated its FY 2025 earnings guidance on Tuesday, May, 6th. The company provided earnings per share (EPS) guidance of -0.020-0.020 for the period, compared to the consensus earnings per share estimate of 0.080. The company issued revenue guidance of $807.0 million-$823.0 million, compared to the consensus revenue estimate of $846.4 million. Did Myriad Genetics beat their earnings estimates last quarter? In the previous quarter, Myriad Genetics (NASDAQ:MYGN) reported ($0.03) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.05) by $0.02. Learn more on analysts' earnings estimate vs. MYGN's actual earnings. How can I listen to Myriad Genetics's earnings conference call? The conference call for Myriad Genetics's latest earnings report can be listened to online. Listen to Conference Call How can I read Myriad Genetics's conference call transcript? The conference call transcript for Myriad Genetics's latest earnings report can be read online. Read Transcript How can I view Myriad Genetics's earnings report? Myriad Genetics's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Myriad Genetics generate each year? Myriad Genetics (NASDAQ:MYGN) has a recorded annual revenue of $837.60 million. How much profit does Myriad Genetics generate each year? Myriad Genetics (NASDAQ:MYGN) has a recorded net income of -$263.30 million. MYGN has generated -$1.12 earnings per share over the last four quarters. What is Myriad Genetics's EPS forecast for next year? Myriad Genetics's earnings are expected to stay at ($0.30) per share in the next year. More Earnings Resources from MarketBeat Related Companies BioCryst Pharmaceuticals Earnings Date Ligand Pharmaceuticals Earnings Date Amicus Therapeutics Earnings Date MannKind Earnings Date Dynavax Technologies Earnings Date Celldex Therapeutics Earnings Date Innoviva Earnings Date Novavax Earnings Date OPKO Health Earnings Date Geron Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum HoldsWhy Nearly 20 Analysts Raised Meta Price Targets Post-EarningsOXY Stock Rebound Begins Following Solid Earnings BeatMonolithic Power Systems: Will Strong Earnings Spark a Recovery?Datadog Earnings Delight: Q1 Strength and an Upbeat Forecast Upwork's Earnings Beat Fuels Stock Rally—Is Freelancing Booming? This page (NASDAQ:MYGN) was last updated on 5/12/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredDrop these 5 stocks now!You think the volatility is over? Think again … Because it’s just getting started. In fact, according...Weiss Ratings | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Myriad Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Myriad Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MYGN Stock Free MYGN Stock Alerts